226 related articles for article (PubMed ID: 24846460)
1. Anticancer hybrids--a patent survey.
Nepali K; Sharma S; Kumar D; Budhiraja A; Dhar KL
Recent Pat Anticancer Drug Discov; 2014; 9(3):303-39. PubMed ID: 24846460
[TBL] [Abstract][Full Text] [Related]
2. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
[TBL] [Abstract][Full Text] [Related]
4. Recent advances (2015-2016) in anticancer hybrids.
Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
[TBL] [Abstract][Full Text] [Related]
5. An overview of molecular hybrids in drug discovery.
Bérubé G
Expert Opin Drug Discov; 2016; 11(3):281-305. PubMed ID: 26727036
[TBL] [Abstract][Full Text] [Related]
6. Advances in the development of hybrid anticancer drugs.
Fortin S; Bérubé G
Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Compounds as Direct Multitarget Ligands: A Review.
de Oliveira Pedrosa M; Duarte da Cruz RM; de Oliveira Viana J; de Moura RO; Ishiki HM; Barbosa Filho JM; Diniz MF; Scotti MT; Scotti L; Bezerra Mendonca FJ
Curr Top Med Chem; 2017; 17(9):1044-1079. PubMed ID: 27697048
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
Sousa JB; Fresco P; Diniz C; Goncalves J
Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Compounds as Multitarget Directed Anticancer Agents.
Kucuksayan E; Ozben T
Curr Top Med Chem; 2017; 17(8):907-918. PubMed ID: 27697050
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
11. Marine Derived Anticancer Drugs Targeting Microtubule.
De O; Chatterji BP
Recent Pat Anticancer Drug Discov; 2017; 12(2):102-127. PubMed ID: 28067173
[TBL] [Abstract][Full Text] [Related]
12. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).
Collina S; Bignardi E; Rui M; Rossi D; Gaggeri R; Zamagni A; Cortesi M; Tesei A
Expert Opin Ther Pat; 2017 May; 27(5):565-578. PubMed ID: 28051882
[TBL] [Abstract][Full Text] [Related]
13. Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids.
Singh AK; Kumar A; Singh H; Sonawane P; Paliwal H; Thareja S; Pathak P; Grishina M; Jaremko M; Emwas AH; Yadav JP; Verma A; Khalilullah H; Kumar P
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145292
[TBL] [Abstract][Full Text] [Related]
14. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review.
Adhikari N; Amin SA; Jha T
Pharm Pat Anal; 2018 Nov; 7(6):259-276. PubMed ID: 30632447
[TBL] [Abstract][Full Text] [Related]
15. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations.
Dara A; Sangamwar AT
Expert Opin Ther Pat; 2014 Aug; 24(8):893-912. PubMed ID: 24898985
[TBL] [Abstract][Full Text] [Related]
16. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).
Leoni A; Locatelli A; Morigi R; Rambaldi M
Expert Opin Ther Pat; 2016; 26(2):149-73. PubMed ID: 26561198
[TBL] [Abstract][Full Text] [Related]
17. Na+/K+-ATPase and cancer.
Mijatovic T; Dufrasne F; Kiss R
Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
[TBL] [Abstract][Full Text] [Related]
18. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
19. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
20. A patent review of two fruitful decades (1997-2016) of Isocoumarin research.
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Nov; 27(11):1267-1275. PubMed ID: 28621561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
